The short answer
High-dose pyridoxine may lower phenytoin concentrations, so discuss it with your prescriber before use. Evidence is limited and does not establish the effect of lower doses or every B6 form. Needed deficiency treatment should be planned, not stopped because of a blanket warning.
What this answer covers
Oral vitamin B6, particularly high-dose pyridoxine, with phenytoin; different vitamers and nutritional amounts are not assumed equivalent.
- Supplement or preparation
- Vitamin B6
- Medication ingredient
- phenytoin
The warning rests on limited high-dose evidence
Federal nutrient guidance describes reduced phenytoin levels in reports involving high-dose pyridoxine. The old original letter could be identified but its clinical details were not accessible. Lower-dose effects and the precise mechanism remain uncertain.
A later mixed-vitamin study had different findings
An open pilot reported stable monitored conventional antiseizure-drug levels during a multivitamin regimen. It was small, uncontrolled and did not isolate B6 or report a reliable phenytoin subgroup effect. It also contained an inconsistent B6 dose statement.
Nutrition and drug exposure are separate questions
Phenytoin can affect vitamin status, while a high-dose supplement may affect medication handling. A deficiency assessment and a drug-interaction assessment can both be appropriate. Neither means everyone should take high doses or avoid all B6-containing foods.
Review amount and monitoring together
Bring the B6 form and total daily amount from all products to your clinician. No specific dose gap has been shown to prevent the possible concentration change. Do not change phenytoin yourself or abandon prescribed vitamin treatment without a coordinated plan.
Evidence and practical considerations
Absorption & effectiveness
High-dose pyridoxine may lower phenytoin concentrations, so discuss it with your prescriber before use. Evidence is limited and does not establish the effect of lower doses or every B6 form. Needed deficiency treatment should be planned, not stopped because of a blanket warning.
- Exact scope
- Oral vitamin B6, particularly high-dose pyridoxine, with phenytoin; different vitamers and nutritional amounts are not assumed equivalent. with Oral phenytoin; free-acid and sodium-salt formulations are explicitly distinguished.
- Medication form and route
- oral
What remains uncertain
- No universal risk rate or dose interval is established. Specific original-source limitations and access status are documented.
Factors that may matter: Exact preparation and amount; Medication formulation and drug levels; Seizure history and other treatments.
Read the supporting source summaries
Source 1: Current U.S. regulatory labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral phenytoin for supported seizure indications.
Labels name folic acid and St John’s wort as possible causes of lower phenytoin levels. Calcium-carbonate and magnesium-hydroxide antacids should not be taken simultaneously. Abrupt withdrawal can worsen seizures.
How this applies: Exact medication precautions with the formulation bridge explicitly retained.
A generic mineral is not every antacid salt. Free-acid and sodium formulations have different drug content; oral absorption findings do not apply to intravenous administration.
Source 2: Federal nutrient guidance
ods.od.nih.gov · Source check Sep 10, 2026
Population: People using phenytoin or certain other antiseizure medicines.
Describes limited evidence that 200 mg/day can lower phenytoin concentrations; effects of lower doses are uncertain.
How this applies: Supports a high-dose monitoring precaution, not proven malabsorption or a safe threshold for all B6 forms.
Underlying 1976 letter has no indexed abstract and publisher body was unavailable. Its numerical results are not claimed as independently verified.
Source 3: Original open-label clinical cohort
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Thirty adults with refractory focal epilepsy;26 completed.
Authors reported stable monitored conventional-drug levels and improved average seizure frequency; three participants reported worsening seizures.
How this applies: Contrary context without erasing high-dose concerns or isolating B6 effects.
Uncontrolled mixture, small sample and no phenytoin-specific outcome estimate. B6 is 100 mg in Methods but 5 mg in one Discussion sentence; no fixed-dose safety claim is made. Worsening cases all used levetiracetam, with other treatment present.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial source-checked research draft with exact formulation limits, contrary evidence and source-access details. Clinical review not recorded. | |
| Research summary published |
Article revision: 9aa5c1231daa9b22
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.